A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

DuPont ™ Liveo™ for Healthcare Silicone Solutions Is Introduced

DuPont is a globally recognized leader in silicone-based technology with more than 70 years of experience advancing healthcare through materials innovation, is introducing DuPont Liveo, a new brand name for its extensive range of silicone healthcare solutions. The news was announced today.

Inspired by the terms “live” and “to be alive,” the new Liveo brand name reflects DuPont Healthcare’s drive to create next-generation, innovative solutions that can help patients live life to the fullest.

“As the new name for the longest legacy in healthcare applied silicones brought by DOW CORNING, Liveo stands for smarter healthcare and positive patient outcomes,” says DuPont Liveo Healthcare Global Marketing Manager Jennifer Gemo Mathis.

More than a name change, the Liveo brand reinforces DuPont’s commitment in healthcare and renewed energy to build on more than 70 years of innovation development capabilities, regulatory and manufacturing know-how, and application expertise.

Historically marketed with a DOW CORNING or SILASTIC trade name, the product offering and packaging material are not changing, and all locations will continue to manufacture the same products, using the same rigorous processes and quality oversight as before. Looking ahead, the Liveo brand will reinforce DuPont’s competitive advantages and leadership positions in three key healthcare markets – Biopharmaceutical Processing, Pharmaceutical Solutions and Medical Devices.

“We are making significant investments in both capital and resources to strengthen our strategic capabilities to support our customers’ leadership in key healthcare industry market segments, and we are particularly proud of the contribution that our teams and products have provided to our customers without disruptions during the COVID-19 pandemic outbreak,” says DuPont Liveo Healthcare Global Business Director Eugenio Toccalino.

The Liveo brand product line includes pharma tubing and overmolded assemblies for single-use systems in biopharma processing, transdermal and topical drug delivery systems, medical adhesives for advanced wound care and ostomy care and wearables, silicone elastomers for a wide range of specialty medical devices, anti-flatulent active pharmaceutical ingredients, silicone antifoams, coating, fluids, emulsions and much more. The Liveo product line continues to be manufactured at the DuPont Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan, USA, which is an ISO 9001:2015 and ISO 14000 registered site and FDA registered utilizing GMPs.

 

SourceDupont
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy